Long-term programming of Antigen-specific immunity from gene expression signatures in the PBMC of rhesus macaques immunized with an SIV DNA vaccine

PLoS ONE

Volumn 6, Issue 6, 2011, Pages

  Belisle, Sarah E ^a   Yin, Jiangmei ^b   Shedlock, Devon J ^b   Dai, Anlan ^b   Yan, Jian ^b   Hirao, Lauren ^b   Kutzler, Michele A ^c   Lewis, Mark G ^d   Andersen, Hanne ^d   Lank, Simon M ^e   Karl, Julie A ^e   O'Connor, David H ^e   Khan, Amir ^f   Sardesai, Niranjan ^f   Chang, Jean ^a   Aicher, Lauri ^a   Palermo, Robert E ^a   Weiner, David B ^b   Katze, Michael G ^a   Boyer, Jean ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^d Research Section   (United States)

^e UNIVERSITY OF WISCONSIN   (United States)

^f Inovio Pharmaceuticals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; DNA VACCINE; GAG PROTEIN; INTERFERON; PLASMID DNA; POL PROTEIN; RANTES; VIRUS ENVELOPE PROTEIN; GAMMA INTERFERON; SIMIAN IMMUNODEFICIENCY VIRUS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; CD8+ T LYMPHOCYTE; CELL MIGRATION; CELLULAR IMMUNITY; CONTROLLED STUDY; ELECTROPORATION; EX VIVO STUDY; GENE EXPRESSION REGULATION; GENE SEQUENCE; HIGH THROUGHPUT SEQUENCING; IMMUNOASSAY; MEMORY T LYMPHOCYTE; MICROARRAY ANALYSIS; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; RHESUS MONKEY; SIGNAL TRANSDUCTION; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; T LYMPHOCYTE ACTIVATION; UPREGULATION; VIREMIA; VIRUS REPLICATION; ANIMAL; DNA MICROARRAY; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; IMMUNOLOGY; MACACA MULATTA; METABOLISM; MONONUCLEAR CELL;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS 1; MACACA MULATTA; SIMIAN IMMUNODEFICIENCY VIRUS;

ANIMALS; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; INTERFERON-GAMMA; LEUKOCYTES, MONONUCLEAR; MACACA MULATTA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SAIDS VACCINES; VACCINES, DNA;

EID: 79959312832     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0019681     Document Type: Article

References (62)

1. Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, Kaewkungwal J, Chiu J, et al. (2009) Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N Engl J Med 361: 2209-2220.
2. Klenerman P, Hill A, (2005) T cells and viral persistence: lessons from diverse infections. Nat Immunol 6: 873-879.
3. McMichael AJ, Rowland-Jones SL, (2001) Cellular immune responses to HIV. Nature 410: 980-987.
4. Karlsson I, Malleret B, Brochard P, Delache B, Calvo J, et al. (2007) Dynamics of T-cell responses and memory T cells during primary simian immunodeficiency virus infection in cynomolgus macaques. J Virol 81: 13456-13468.
5. Borrow P, Lewicki H, Hahn BH, Shaw GM, Oldstone MB, (1994) Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J Virol 68: 6103-6110.
6. Koup RA, Safrit JT, Cao Y, Andrews CA, McLeod G, et al. (1994) Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J Virol 68: 4650-4655.
7. Musey L, Hughes J, Schacker T, Shea T, Corey L, et al. (1997) Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection. N Engl J Med 337: 1267-1274.
8. Ogg GS, Jin X, Bonhoeffer S, Dunbar PR, Nowak MA, et al. (1998) Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science 279: 2103-2106.
9. Wilson JD, Ogg GS, Allen RL, Davis C, Shaunak S, et al. (2000) Direct visualization of HIV-1-specific cytotoxic T lymphocytes during primary infection. AIDS 14: 225-233.
10. Yasutomi Y, Reimann KA, Lord CI, Miller MD, Letvin NL, (1993) Simian immunodeficiency virus-specific CD8+ lymphocyte response in acutely infected rhesus monkeys. J Virol 67: 1707-1711.
11. Migueles SA, Laborico AC, Shupert WL, Sabbaghian MS, Rabin R, et al. (2002) HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors. Nat Immunol 3: 1061-1068.
12. Betts MR, Nason MC, West SM, De Rosa SC, Migueles SA, et al. (2006) HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood 107: 4781-4789.
13. Schmitz JE, Kuroda MJ, Santra S, Sasseville VG, Simon MA, et al. (1999) Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science 283: 857-860.
14. Jin X, Bauer DE, Tuttleton SE, Lewin S, Gettie A, et al. (1999) Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques. J Exp Med 189: 991-998.
15. Day CL, Kaufmann DE, Kiepiela P, Brown JA, Moodley ES, et al. (2006) PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 443: 350-354.
16. Freeman GJ, Wherry EJ, Ahmed R, Sharpe AH, (2006) Reinvigorating exhausted HIV-specific T cells via PD-1-PD-1 ligand blockade. J Exp Med 203: 2223-2227.
17. Petrovas C, Casazza JP, Brenchley JM, Price DA, Gostick E, et al. (2006) PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection. J Exp Med 203: 2281-2292.
18. Petrovas C, Price DA, Mattapallil J, Ambrozak DR, Geldmacher C, et al. (2007) SIV-specific CD8+ T cells express high levels of PD1 and cytokines but have impaired proliferative capacity in acute and chronic SIVmac251 infection. Blood 110: 928-936.
19. Velu V, Kannanganat S, Ibegbu C, Chennareddi L, Villinger F, et al. (2007) Elevated expression levels of inhibitory receptor programmed death 1 on simian immunodeficiency virus-specific CD8 T cells during chronic infection but not after vaccination. J Virol 81: 5819-5828.
20. Alkhatib G, Combadiere C, Broder CC, Feng Y, Kennedy PE, et al. (1996) CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272: 1955-1958.
21. Cocchi F, DeVico AL, Garzino-Demo A, Arya SK, Gallo RC, et al. (1995) Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Science 270: 1811-1815.
22. Proudfoot AE, Wells TN, Clapham PR, (1999) Chemokine receptors-future therapeutic targets for HIV? Biochem Pharmacol 57: 451-463.
23. Bonecchi R, Bianchi G, Bordignon PP, D'Ambrosio D, Lang R, et al. (1998) Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med 187: 129-134.
24. Loetscher P, Uguccioni M, Bordoli L, Baggiolini M, Moser B, et al. (1998) CCR5 is characteristic of Th1 lymphocytes. Nature 391: 344-345.
25. Sallusto F, Lanzavecchia A, Mackay CR, (1998) Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses. Immunol Today 19: 568-574.
26. Imami N, Pires A, Hardy G, Wilson J, Gazzard B, et al. (2002) A balanced type 1/type 2 response is associated with long-term nonprogressive human immunodeficiency virus type 1 infection. J Virol 76: 9011-9023.
27. Kim JJ, Nottingham LK, Sin JI, Tsai A, Morrison L, et al. (1998) CD8 positive T cells influence antigen-specific immune responses through the expression of chemokines. J Clin Invest 102: 1112-1124.
28. Xin KQ, Lu Y, Hamajima K, Fukushima J, Yang J, et al. (1999) Immunization of RANTES expression plasmid with a DNA vaccine enhances HIV-1-specific immunity. Clin Immunol 92: 90-96.
29. Frauenschuh A, DeVico AL, Lim SP, Gallo RC, Garzino-Demo A, (2004) Differential polarization of immune responses by co-administration of antigens with chemokines. Vaccine 23: 546-554.
30. Waterman PM, Kitabwalla M, Hatfield GS, Evans PS, Lu Y, et al. (2004) Effects of virus burden and chemokine expression on immunity to SHIV in nonhuman primates. Viral Immunol 17: 545-557.
31. Migueles SA, Osborne CM, Royce C, Compton AA, Joshi RP, et al. (2008) Lytic granule loading of CD8+ T cells is required for HIV-infected cell elimination associated with immune control. Immunity 29: 1009-1021.
32. Miller JD, van der Most RG, Akondy RS, Glidewell JT, Albott S, et al. (2008) Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines. Immunity 28: 710-722.
33. Giri MS, Nebozyhn M, Raymond A, Gekonge B, Hancock A, et al. (2009) Circulating monocytes in HIV-1-infected viremic subjects exhibit an antiapoptosis gene signature and virus- and host-mediated apoptosis resistance. J Immunol 182: 4459-4470.
34. Ockenhouse CF, Bernstein WB, Wang Z, Vahey MT, (2005) Functional genomic relationships in HIV-1 disease revealed by gene-expression profiling of primary human peripheral blood mononuclear cells. J Infect Dis 191: 2064-2074.
35. Bosinger SE, Hosiawa KA, Cameron MJ, Persad D, Ran L, et al. (2004) Gene expression profiling of host response in models of acute HIV infection. J Immunol 173: 6858-6863.
36. Li Q, Smith AJ, Schacker TW, Carlis JV, Duan L, et al. (2009) Microarray analysis of lymphatic tissue reveals stage-specific, gene expression signatures in HIV-1 infection. J Immunol 183: 1975-1982.
37. Romano JW, Shurtliff RN, Dobratz E, Gibson A, Hickman K, et al. (2000) Quantitative evaluation of simian immunodeficiency virus infection using NASBA technology. J Virol Methods 86: 61-70.
38. Kutzler MA, Robinson TM, Chattergoon MA, Choo DK, Choo AY, et al. (2005) Coimmunization with an optimized IL-15 plasmid results in enhanced function and longevity of CD8 T cells that are partially independent of CD4 T cell help. J Immunol 175: 112-123.
39. Prud'homme GJ, Glinka Y, Khan AS, Draghia-Akli R, (2006) Electroporation-enhanced nonviral gene transfer for the prevention or treatment of immunological, endocrine and neoplastic diseases. Curr Gene Ther 6: 243-273.
40. Hirao LA, Wu L, Khan AS, Hokey DA, Yan J, et al. (2008) Combined effects of IL-12 and electroporation enhances the potency of DNA vaccination in macaques. Vaccine 26: 3112-3120.
41. Yin J, Dai A, Laddy DJ, Yan J, Arango T, et al. (2009) High dose of plasmid IL-15 inhibits immune responses in an influenza non-human primates immunogenicity model. Virology 393: 49-55.
42. Betts MR, Casazza JP, Patterson BA, Waldrop S, Trigona W, et al. (2000) Putative immunodominant human immunodeficiency virus-specific CD8(+) T-cell responses cannot be predicted by major histocompatibility complex class I haplotype. J Virol 74: 9144-9151.
43. Karl JA, Wiseman RW, O'Connor DH, (2009) Cost-effective sequence-based nonhuman primate MHC class I genotyping from RNA. Methods 49: 11-17.
44. Wiseman RW, Karl JA, Bimber BN, O'Leary CE, Lank SM, et al. (2009) Major histocompatibility complex genotyping with massively parallel pyrosequencing. Nat Med 15: 1322-1326.
45. Loffredo JT, Maxwell J, Qi Y, Glidden CE, Borchardt GJ, et al. (2007) Mamu-B*08-positive macaques control simian immunodeficiency virus replication. J Virol 81: 8827-8832.
46. Loffredo JT, Sidney J, Bean AT, Beal DR, Bardet W, et al. (2009) Two MHC class I molecules associated with elite control of immunodeficiency virus replication, Mamu-B*08 and HLA-B*2705, bind peptides with sequence similarity. J Immunol 182: 7763-7775.
47. Mothe BR, Weinfurter J, Wang C, Rehrauer W, Wilson N, et al. (2003) Expression of the major histocompatibility complex class I molecule Mamu-A*01 is associated with control of simian immunodeficiency virus SIVmac239 replication. J Virol 77: 2736-2740.
48. Sauermann U, Siddiqui R, Suh YS, Platzer M, Leuchte N, et al. (2008) Mhc class I haplotypes associated with survival time in simian immunodeficiency virus (SIV)-infected rhesus macaques. Genes Immun 9: 69-80.
49. Yant LJ, Friedrich TC, Johnson RC, May GE, Maness NJ, et al. (2006) The high-frequency major histocompatibility complex class I allele Mamu-B*17 is associated with control of simian immunodeficiency virus SIVmac239 replication. J Virol 80: 5074-5077.
50. Nishimura Y, Igarashi T, Buckler-White A, Buckler C, Imamichi H, et al. (2007) Loss of naive cells accompanies memory CD4+ T-cell depletion during long-term progression to AIDS in Simian immunodeficiency virus-infected macaques. J Virol 81: 893-902.
51. Brenchley JM, Schacker TW, Ruff LE, Price DA, Taylor JH, et al. (2004) CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med 200: 749-759.
52. Veazey RS, Mansfield KG, Tham IC, Carville AC, Shvetz DE, et al. (2000) Dynamics of CCR5 expression by CD4(+) T cells in lymphoid tissues during simian immunodeficiency virus infection. J Virol 74: 11001-11007.
53. Guadalupe M, Reay E, Sankaran S, Prindiville T, Flamm J, et al. (2003) Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy. J Virol 77: 11708-11717.
54. Sin J, Kim JJ, Pachuk C, Satishchandran C, Weiner DB, (2000) DNA vaccines encoding interleukin-8 and RANTES enhance antigen-specific Th1-type CD4(+) T-cell-mediated protective immunity against herpes simplex virus type 2 in vivo. J Virol 74: 11173-11180.
55. Shimizu Y, Inaba K, Kaneyasu K, Ibuki K, Himeno A, et al. (2007) A genetically engineered live-attenuated simian-human immunodeficiency virus that co-expresses the RANTES gene improves the magnitude of cellular immunity in rhesus macaques. Virology 361: 68-79.
56. Batten M, Kljavin NM, Li J, Walter MJ, de Sauvage FJ, et al. (2008) Cutting Edge: IL-27 Is a Potent Inducer of IL-10 but Not FoxP3 in Murine T Cells. J Immunol 180: 2752-2756.
57. Gosselin A, Monteiro P, Chomont N, Diaz-Griffero F, Said EA, et al. (2010) Peripheral blood CCR4+CCR6+ and CXCR3+CCR6+CD4+ T cells are highly permissive to HIV-1 infection. J Immunol 184: 1604-1616.
58. Cecchinato V, Trindade CJ, Laurence A, Heraud JM, Brenchley JM, et al. (2008) Altered balance between Th17 and Th1 cells at mucosal sites predicts AIDS progression in simian immunodeficiency virus-infected macaques. Mucosal Immunol 1: 279-288.
59. Lanzavecchia A, Sallusto F, (2000) Dynamics of T lymphocyte responses: intermediates, effectors, and memory cells. Science 290: 92-97.
60. Shiow LR, Rosen DB, Brdickova N, Xu Y, An J, et al. (2006) CD69 acts downstream of interferon-alpha/beta to inhibit S1P1 and lymphocyte egress from lymphoid organs. Nature 440: 540-544.
61. Hadida F, Vieillard V, Autran B, Clark-Lewis I, Baggiolini M, et al. (1998) HIV-specific T cell cytotoxicity mediated by RANTES via the chemokine receptor CCR3. J Exp Med 188: 609-614.
62. Hadida F, Vieillard V, Mollet L, Clark-Lewis I, Baggiolini M, et al. (1999) Cutting edge: RANTES regulates Fas ligand expression and killing by HIV-specific CD8 cytotoxic T cells. J Immunol 163: 1105-1109.